Chapter/Section Purchase

1 Study Coverage
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Market by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region
2.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2023-2028)
2.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region
2.5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022)
2.5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturers
3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs in 2021
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturers
3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2021
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type
4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type
4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type
4.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2022)
4.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application
5.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application
5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application
5.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2022)
5.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
6.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
6.2.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
6.2.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
6.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
6.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
6.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
7.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
7.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
7.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
7.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
7.3.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
7.3.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
8.1.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
8.2.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region
8.3.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
9.1.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
9.1.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
9.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
9.2.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
9.2.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
9.3 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
9.3.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
9.3.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
10.1.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
10.2.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
10.3.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Corporation Information
11.1.2 Merck & Co., Inc. Overview
11.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co., Inc. Recent Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Corporation Information
11.2.2 GlaxoSmithKline plc Overview
11.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline plc Recent Developments
11.3 Tesaro, Inc.
11.3.1 Tesaro, Inc. Corporation Information
11.3.2 Tesaro, Inc. Overview
11.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Tesaro, Inc. Recent Developments
11.4 Helsinn Group
11.4.1 Helsinn Group Corporation Information
11.4.2 Helsinn Group Overview
11.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Helsinn Group Recent Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd. Overview
11.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.6 Heron Therapeutics, Inc.
11.6.1 Heron Therapeutics, Inc. Corporation Information
11.6.2 Heron Therapeutics, Inc. Overview
11.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heron Therapeutics, Inc. Recent Developments
11.7 Dr. Reddy's Laboratories Ltd.
11.7.1 Dr. Reddy's Laboratories Ltd. Corporation Information
11.7.2 Dr. Reddy's Laboratories Ltd. Overview
11.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dr. Reddy's Laboratories Ltd. Recent Developments
11.8 Acacia Pharma
11.8.1 Acacia Pharma Corporation Information
11.8.2 Acacia Pharma Overview
11.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Acacia Pharma Recent Developments
11.9 Sun Pharmaceutical Industry Ltd.
11.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
11.9.2 Sun Pharmaceutical Industry Ltd. Overview
11.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharmaceutical Industry Ltd. Recent Developments
11.10 Otsuka Holdings Co., Ltd.
11.10.1 Otsuka Holdings Co., Ltd. Corporation Information
11.10.2 Otsuka Holdings Co., Ltd. Overview
11.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Otsuka Holdings Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Analysis
12.2 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Chemotherapy-Induced Nausea and Vomiting Drugs Production Mode & Process
12.4 Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Marketing
12.4.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channels
12.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
12.5 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
13.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
13.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
13.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
14 Key Findings in The Global Chemotherapy-Induced Nausea and Vomiting Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer